跳至主要内容
临床试验/CTRI/2026/07/114024
CTRI/2026/07/114024进行中(未招募)不适用

Digital Biopsy based Non Invasive Clinical Decision Support for Precision Medicine and Deepfake Resilience for Trustworthy AI in Radiology - NIL

Indian Institute of Science0 个研究点目标入组 1,000 人开始时间: 2026年7月31日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patient with histopathologically confirmed Stage 3 or Stage 4 cancers or Grade 4 tumors.
  • Availability of baseline medical imaging like MRI,CT,PET or any other relevant imaging modalities performed as a part of routine diagnostic care.
  • Availability of complete and verifiable medical electronic records, including molecular or genomic status confirmed by standard tissue biopsy.

排除标准

  • Incomplete or unavailable electronic medical records, including molecular or genomic status.
  • Poor quality medical images that are unsuitable for radiomics analysis.
  • Presence of conditions that interfere with accurate tumor assessment on imaging like extensive infection or inflammation or concurrent lesions.
  • Previous surgeriesin the region of interest prior to baseline scans that affect radiomics feature extraction.
  • Presence of metallic implants, pacemakers or other foreign bodies that can cause severe imaging artifacts.
  • Unconfirmed or unverified histopathological diagnosis.

研究者

相似试验